Please login to the form below

Not currently logged in
Email:
Password:

Marathon Pharma

This page shows the latest Marathon Pharma news and features for those working in and with pharma, biotech and healthcare.

Pfizer abandons antibody for Duchenne

Pfizer abandons antibody for Duchenne

The big pharma company halted two trials of the anti-myostatin antibody, which is designed to build muscle mass and strength. ... At the moment these are the only two drugs available to treat the underlying dystrophin gene mutation in some DMD patients,

Latest news

More from news
Approximately 2 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • A marathon and a sprint A marathon and a sprint

    It seems some pharma companies are not quite out of the starting blocks. ... Pharma’s CX marathon involves multiple participants; prescribers, policy-makers, regulators, payers, patients, carers and, as the prevention agenda gathers pace, ‘healthy’

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
COUCH Health

We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...

Infographics